本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Oric Pharmaceuticals Inc.

13.83
+0.37002.75%
盤後13.830.00000.00%16:20 EDT
成交量:116.88萬
成交額:1,622.31萬
市值:14.32億
市盈率:-10.23
高:14.15
開:13.71
低:13.52
收:13.46
52周最高:14.93
52周最低:7.23
股本:1.04億
流通股本:8,868.67萬
量比:1.04
換手率:1.32%
股息:- -
股息率:- -
每股收益(TTM):-1.3513
每股收益(LYR):-1.4747
淨資產收益率:-39.80%
總資產收益率:-25.97%
市淨率:3.76
市盈率(LYR):-9.38

資料載入中...

2023/08/10

重要事件披露

Form 8-K - Current report
2023/08/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/08

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/07/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/27

重要事件披露

Form 8-K - Current report
2023/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/16

重要事件披露

Form 8-K - Current report
2023/06/12

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/05/08

重要事件披露

8-K - Current report
2023/05/08

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/03/24

重要事件披露

8-K - Current report
2023/03/16

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/16

重要事件披露

8-K - Current report
2023/03/16

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/13

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/06

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/20

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/01/09

重要事件披露

8-K - Current report
2022/12/29

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals